Abacus Life, Inc. (ABL)
(Real Time Quote from BATS)
$11.00 USD
+0.22 (2.04%)
Updated Jul 24, 2024 01:02 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ABL 11.00 +0.22(2.04%)
Will ABL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ABL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABL
Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?
ABL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ABL
Western Alliance Posts Upbeat Earnings, Joins Abacus Life, SLB And Other Big Stocks Moving Higher On Friday
Morgan Stanley Keeps Their Hold Rating on Abbott Laboratories (ABT)
Maintained Buy Rating for Abbott Laboratories on Strong Financials and Growth Prospects
Abacus Life Provides Preliminary Second Quarter 2024 Results
Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA